Sacral neuromodulation (SNM) has been used off-label in the United States for over a decade in the pediatric population. Many published studies have demonstrated efficacy with SNM in this population, however, a significant number of children with refractory bowel bladder dysfunction (BBD) also have underlying co-morbidities.